Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Edesa Biotech, Inc. (EDSA) vs Elicio Therapeutics, Inc. (ELTX)

Edesa Biotech, Inc. and Elicio Therapeutics, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and Elicio Therapeutics, Inc. are of similar size ($54.5M and $53.4M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against −43.5%. Across the 12 metrics below, Elicio Therapeutics, Inc. leads on 7 and Edesa Biotech, Inc. on 5.

Valuation

Metric EDSA ELTX Biotechnology median
P/E n/m n/m 7.88
P/S 109.85 1.23 11.47
P/B 90.52 4.46 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 78.42 0.78 10.73
Earnings yield (42.14%) (117.93%) (28.84%)
Free cash flow yield (24.68%) (106.74%) (23.03%)

Profitability

Metric EDSA ELTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (531.32%) (774.56%) (57.72%)
Return on assets (102.46%) (124.36%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDSA ELTX Biotechnology median
Revenue growth (TTM) (43.48%) 921.02% 5.64%
EPS growth (last fiscal year) 34.20% 39.29% —
Revenue growth, 5-year CAGR (15.40%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDSA ELTX Biotechnology median
Debt to equity 0.00 1.20 0.00
Current ratio 2.76 2.77 4.73
Net debt to EBITDA 1.39 0.25 0.96

Dividend

Metric EDSA ELTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EDSA ELTX Biotechnology median
Market cap 54.45m 53.35m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack